Dexcel Pharma Drug Patent Portfolio

Dexcel Pharma owns 1 orange book drug protected by 1 US patent Given below is the list of Dexcel Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9023391 Stable benzimidazole formulation 16 Aug, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Dexcel Pharma.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 09 May, 2024 US10835488
Payment of Maintenance Fee, 8th Year, Large Entity 26 Oct, 2022 US9023391 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 14 Feb, 2022 US10076494
Recordation of Patent Grant Mailed 17 Nov, 2020 US10835488
Patent Issue Date Used in PTA Calculation 17 Nov, 2020 US10835488
Email Notification 29 Oct, 2020 US10835488
Issue Notification Mailed 28 Oct, 2020 US10835488
Mailing Corrected Notice of Allowability 13 Oct, 2020 US10835488
Email Notification 13 Oct, 2020 US10835488
Dispatch to FDC 10 Oct, 2020 US10835488
Information Disclosure Statement considered 07 Oct, 2020 US10835488
Corrected Notice of Allowability 07 Oct, 2020 US10835488
Pubs Case Remand to TC 05 Oct, 2020 US10835488
Record Petition Decision of Granted to Withdraw from Issue 17 Sep, 2020 US10835488
Workflow - Request for RCE - Finish 17 Sep, 2020 US10835488


Dexcel Pharma's Family Patents

Dexcel Pharma drugs have patent protection in a total of 8 countries. It's US patent count contributes only to 35.7% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Dexcel Pharma Drug List

Given below is the complete list of Dexcel Pharma's drugs and the patents protecting them.


1. Omeprazole

Omeprazole is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9023391 Stable benzimidazole formulation 16 Aug, 2025
(7 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omeprazole's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dexcel Pharma News

Validity of Pfizer's initial Vyndamax patent case faces scrutiny - Bloomberg Law reports

26 Jan, 2024

See More